Ferric derisomaltose and tranexamic acid, combined or alone, for reducing blood transfusion in patients with hip fracture (the HiFIT trial): a multicentre, 2 × 2 factorial, randomised, double-blind, controlled trialSigismond Lasocki, Pierre Bouzat, Louis Rony et al.|The Lancet Haematology|2023Cited by 29